Association between intestinal microbiota and inflammatory bowel disease

Area of Science:

• Gastroenterology and Immunology
• Microbiome Research

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a prevalent global condition with significant morbidity.
• The exact etiology of IBD remains incompletely understood, despite extensive research into its pathogenesis and therapeutic strategies.
• Gut microbiota dysbiosis is recognized as a hallmark of IBD, but its causal role is still debated.

Purpose of the Study:

• To review current knowledge on mouse models used to study IBD pathogenesis.
• To examine the contribution of gut microbiota alterations to IBD development.
• To explore the link between dysregulated metabolite production and IBD pathogenesis.

Main Methods:

• Review of literature on chemically induced and infectious mouse models of IBD.
• Analysis of studies investigating gut microbiota composition and function in IBD.
• Examination of research on the role of microbial metabolites in IBD pathogenesis.

Main Results:

• Various mouse models provide insights into IBD mechanisms.
• Gut microbiota alterations are consistently observed in IBD patients and models.
• Specific microbial metabolites are implicated in modulating IBD inflammation.

Conclusions:

• Mouse models are crucial for understanding IBD, but their translation to human disease requires careful consideration.
• Further research is needed to elucidate the precise causal relationship between gut microbiota dysbiosis and IBD.
• Targeting microbial metabolites represents a potential therapeutic avenue for IBD.